NR0B1 sensitizes lung cancer cells to chemotherapy and inhibits their invasive abilities [30, 31]; similar effects might explain the poorer survival outcomes observed here in breast cancer patients upon downregulation of this gene. The gene discussed is NR0B1; the disease is breast carcinoma.